Agriculture: Proponents of genetically modified forests could seek the regulatory green light in four years.
Biotech: Microelectronic and communications firms turn to life sciences.
Sensors that monitor vital signs will turn our "sick-care" system into one that preserves wellness.
Isolation of key genes at the heart of Alzheimer's disease has set off a frenzied race to find a drug to stop this cruel affliction in its tracks.
Automated production of highly complex molecules could aid understanding of many major diseases.
Decoy compounds show promise for new drug therapy.
Drug designers will soon be able to tailor medications to the patient's unique genetic makeup, doing more good and less harm.
They can analyze thousands of genes at a time. Here's how.